Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Radius Adds SARM Program From Karo Bio In $17M Deal

Sep. 13, 2006

By Jennifer Boggs

Metastatix Targeting CXCR4 Receptors In Cancer, HIV

Sep. 12, 2006

By Jennifer Boggs

Metastatix Targeting CXCR4 Receptors In Cancer, HIV

Sep. 12, 2006

By Jennifer Boggs

Medivir Licenses Shingles Drug To Antiviral Start-Up Epiphany

Sep. 11, 2006

By Jennifer Boggs

Medivir Licenses Shingles Drug To Antiviral Start-Up Epiphany

Sep. 11, 2006

By Jennifer Boggs

King Buys Ligand's Avinza Rights For $265M Up Front

Sep. 8, 2006

By Jennifer Boggs

RenaMed Adds $40M Privately For Acute Renal Failure Drug

Sep. 8, 2006

By Jennifer Boggs

RenaMed Adds $40M Privately For Acute Renal Failure Drug

Sep. 8, 2006

By Jennifer Boggs

King Buys Ligand's Avinza Rights For $265M Up Front

Sep. 8, 2006

By Jennifer Boggs

Formed To Develop Sepsis Drug, Artisan Raises $39M

Sep. 7, 2006

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...